Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,482 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chemotherapy with bevacizumab for metastatic colorectal cancer: a retrospective review of 181 Japanese patients.
Saito S, Hayashi N, Sato N, Iwatsuki M, Baba Y, Sakamoto Y, Miyamoto Y, Watanabe M, Yoshida M, Sakai K, Katsumori T, Katahuchi S, Shigaki N, Yamada K, Kimura M, Tanigawa T, Takano S, Kuramoto M, Baba H. Saito S, et al. Among authors: miyamoto y. Int J Clin Oncol. 2013 Aug;18(4):689-95. doi: 10.1007/s10147-012-0426-4. Epub 2012 Jun 5. Int J Clin Oncol. 2013. PMID: 22664951 Clinical Trial.
Chemotherapy is effective for stage I gastric cancer in patients with synchronous esophageal cancer.
Osumi H, Yoshio T, Chin K, Ogura M, Kumekawa Y, Suenaga M, Matsusaka S, Shinozaki E, Miyamoto Y, Morishige K, Ishiyama A, Hirasawa T, Tsuchida T, Yamamoto Y, Fujisaki J, Igarashi M, Mizunuma N. Osumi H, et al. Among authors: miyamoto y. Gastric Cancer. 2016 Apr;19(2):625-630. doi: 10.1007/s10120-015-0517-9. Epub 2015 Aug 11. Gastric Cancer. 2016. PMID: 26260873 Clinical Trial.
CXCL12/CXCR4 activation by cancer-associated fibroblasts promotes integrin β1 clustering and invasiveness in gastric cancer.
Izumi D, Ishimoto T, Miyake K, Sugihara H, Eto K, Sawayama H, Yasuda T, Kiyozumi Y, Kaida T, Kurashige J, Imamura Y, Hiyoshi Y, Iwatsuki M, Iwagami S, Baba Y, Sakamoto Y, Miyamoto Y, Yoshida N, Watanabe M, Takamori H, Araki N, Tan P, Baba H. Izumi D, et al. Among authors: miyamoto y. Int J Cancer. 2016 Mar 1;138(5):1207-19. doi: 10.1002/ijc.29864. Epub 2015 Oct 9. Int J Cancer. 2016. PMID: 26414794 Free article.
Clinical Significance of TLR1 I602S Polymorphism for Patients with Metastatic Colorectal Cancer Treated with FOLFIRI plus Bevacizumab.
Okazaki S, Loupakis F, Stintzing S, Cao S, Zhang W, Yang D, Ning Y, Sunakawa Y, Stremitzer S, Matsusaka S, Berger MD, Parekh A, West JD, Miyamoto Y, Suenaga M, Schirripa M, Cremolini C, Falcone A, Heinemann V, DePaolo RW, Lenz HJ. Okazaki S, et al. Among authors: miyamoto y. Mol Cancer Ther. 2016 Jul;15(7):1740-5. doi: 10.1158/1535-7163.MCT-15-0931. Epub 2016 May 11. Mol Cancer Ther. 2016. PMID: 27196764 Free PMC article.
Impact of sex, age, and ethnicity/race on the survival of patients with rectal cancer in the United States from 1988 to 2012.
Berger MD, Yang D, Sunakawa Y, Zhang W, Ning Y, Matsusaka S, Okazaki S, Miyamoto Y, Suenaga M, Schirripa M, Lenz AM, Bohanes P, Barzi A, Figueiredo JC, Hanna DL, Lenz HJ. Berger MD, et al. Among authors: miyamoto y. Oncotarget. 2016 Aug 16;7(33):53668-53678. doi: 10.18632/oncotarget.10696. Oncotarget. 2016. PMID: 27449091 Free PMC article.
Autophagy-related polymorphisms predict hypertension in patients with metastatic colorectal cancer treated with FOLFIRI and bevacizumab: Results from TRIBE and FIRE-3 trials.
Berger MD, Yamauchi S, Cao S, Hanna DL, Sunakawa Y, Schirripa M, Matsusaka S, Yang D, Groshen S, Zhang W, Ning Y, Okazaki S, Miyamoto Y, Suenaga M, Lonardi S, Cremolini C, Falcone A, Heinemann V, Loupakis F, Stintzing S, Lenz HJ. Berger MD, et al. Among authors: miyamoto y. Eur J Cancer. 2017 May;77:13-20. doi: 10.1016/j.ejca.2017.02.020. Epub 2017 Mar 26. Eur J Cancer. 2017. PMID: 28347919 Free PMC article. Clinical Trial.
3,482 results